ANXA2 and neoplasm: In summary, we demonstrated that NASP promotes tumor progression and radioresistance and provides a plausible molecular mechanism involving ANXA2 phosphorylation and nuclear translocation, as well as enhanced STAT3 signaling, which promotes radioresistance and enhances tumorigenic behavior.